News
Sir Kier Starmer has set out his 10-year-plan to reform the NHS in England, based on a shift from hospitals to neighbourhood ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
CVS Caremark will stop covering Eli Lilly's Zepbound, a weight loss drug, due to insurance company changes. Patients are outraged and concerned.
As the NHS rolls out Mounjaro being prescribed by GPs, weight loss jabs have been linked to potentially fatal side effects in new data ...
A new bill could make the price of prescription drugs known for weight loss cheaper for the state to buy for its employees.
It would behoove more Americans to learn how consistent seafood consumption has strong potential to ward off coronary disease ...
Cardiologists need to embrace the wave of new drugs, say experts, particularly since they can reduce the risk of CVD.
Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year ...
Wegovy, a weight-loss injection containing semaglutide, has arrived in India, offering a new approach to combatting obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results